The Journal of Pathology

Epithelial carcinogenesis: challenging monoclonality
pp. 1-3(3)
Author: Going J.J.

ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects–a review
pp. 4-15(12)
Authors: ten Berge R.L.; Oudejans J.J.; Ossenkoppele G.J.; Meijer C.J.

Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer—association with tumour cell proliferation
pp. 16-22(7)
Authors: Grabsch H.; Takeno S.; Parsons W.J.; Pomjanski N.; Boecking A.; Gabbert H.E.; Mueller W.

Concerted promoter hypermethylation of hMLH1, p16^INK4A, and E-cadherin in gastric carcinomas with microsatellite instability
pp. 23-31(9)
Authors: Kim H.; Kim Y.H.; Kim S.E.; Kim N-G.; Noh S.H.; Kim H.

Promoter methylation of TGF receptor I and mutation of TGF receptor II are frequent events in MSI sporadic gastric carcinomas
pp. 32-38(7)
Authors: Pinto M.; Oliveira C.; Cirnes L.; Carlos Machado J.; Ramires M.; Nogueira A.; Carneiro F.; Seruca R.

Tumour suppressor gene expression correlates with gastric cancer prognosis
pp. 39-46(8)
Authors: Lee H.S.; Lee H.K.; Kim H.S.; Yang H-K.; Kim W.H.

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development
pp. 47-52(6)
Authors: Even-Ram S.C.; Grisaru-Granovsky S.; Pruss D.; Maoz M.; Salah Z.; Yong-Jun Y.; Bar-Shavit R.

The role of E-cadherin in low-grade ductal breast tumourigenesis
pp. 53-58(6)
Authors: Roylance R.; Droufakou S.; Gorman P.; Gillett C.; Hart I.R.; Hanby A.; Tomlinson I.

Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit
pp. 59-64(6)
Authors: Sawyer E.J.; Poulsom R.; Hunt F.T.; Jeffery R.; Elia G.; Ellis I.O.; Ellis P.; Tomlinson I.P.; Hanby A.M.

Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) and in bone fractures from men and women
pp. 65-73(9)
Authors: Batra G.S.; Hainey L.; Freemont A.J.; Andrew G.; Saunders P.T.; Hoyland J.A.; Braidman I.P.

Can p53 staining be used to identify patients with aggressive superficial bladder cancer?
pp. 74-81(8)
Authors: Masters J.R.; Vani U.D.; Grigor K.M.; Griffiths G.O.; Crook A.; Parmar M.K.; Knowles M.A.; with the MRC Superficial Bladder Cancer Group Mitomycin-C Trial Collaborators. Contact:

Sustained interleukin-6 signalling leads to the development of lymphoid organ-like structures in the lung
pp. 82-87(6)
Authors: Goya S.; Matsuoka H.; Mori M.; Morishita H.; Kida H.; Kobashi Y.; Kato T.; Taguchi Y.; Osaki T.; Tachibana I.; Nishimoto N.; Yoshizaki K.; Kawase I.; Hayashi S.

hnRNP B1 expression in benign and malignant lung disease
pp. 88-94(7)
Authors: Snead D.; Perunovic B.; Cullen N.; Needham M.; Dhillon D.; Satoh H.; Kamma H.

Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann–Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease
pp. 95-103(9)
Authors: Treiber-Held S.; Distl R.; Meske V.; Albert F.; Ohm T.G.

Cholesterol storage and tau pathology in Niemann–Pick type C disease in the brain
pp. 104-111(8)
Authors: Distl R.; Treiber-Held S.; Albert F.; Meske V.; Harzer K.; Ohm T.G.

Age-related pseudocapillarization of the human liver
pp. 112-117(6)
Authors: McLean A.J.; Cogger V.C.; Chong G.C.; Warren A.; Markus A.M.; Dahlstrom J.E.; Le Couteur D.G.

The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease
pp. 118-129(12)
Authors: Reynolds J.; Moss J.; Duda M.A.; Smith J.; Karkar A.M.; Macherla V.; Shore I.; Evans D.J.; Woodrow D.F.; Pusey C.D.

The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers
pp. 130-136(7)
Authors: Pufe T.; Paulsen F.; Petersen W.; Mentlein R.; Tsokos M.